- Home
- KITT vs LVTX Comparison
KITT vs LVTX Comparison
Compare KITT & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KITT
- LVTX
- Stock Information
- Founded
- KITT 2014
- LVTX 2016
- Country
- KITT United States
- LVTX Netherlands
- Employees
- KITT N/A
- LVTX N/A
- Industry
- KITT Industrial Machinery/Components
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- KITT Industrials
- LVTX Health Care
- Exchange
- KITT Nasdaq
- LVTX Nasdaq
- Market Cap
- KITT 36.4M
- LVTX 41.3M
- IPO Year
- KITT N/A
- LVTX 2021
- Fundamental
- Price
- KITT $3.49
- LVTX $1.54
- Analyst Decision
- KITT
- LVTX Hold
- Analyst Count
- KITT 0
- LVTX 4
- Target Price
- KITT N/A
- LVTX $1.58
- AVG Volume (30 Days)
- KITT 424.7K
- LVTX 104.7K
- Earning Date
- KITT 11-11-2025
- LVTX 08-13-2025
- Dividend Yield
- KITT N/A
- LVTX N/A
- EPS Growth
- KITT N/A
- LVTX N/A
- EPS
- KITT N/A
- LVTX N/A
- Revenue
- KITT $3,082,232.00
- LVTX $4,990,000.00
- Revenue This Year
- KITT $2,936.06
- LVTX N/A
- Revenue Next Year
- KITT N/A
- LVTX N/A
- P/E Ratio
- KITT N/A
- LVTX N/A
- Revenue Growth
- KITT N/A
- LVTX N/A
- 52 Week Low
- KITT $3.29
- LVTX $0.85
- 52 Week High
- KITT $54.36
- LVTX $2.09
- Technical
- Relative Strength Index (RSI)
- KITT 25.25
- LVTX 52.16
- Support Level
- KITT $3.35
- LVTX $1.53
- Resistance Level
- KITT $3.72
- LVTX $1.58
- Average True Range (ATR)
- KITT 0.80
- LVTX 0.03
- MACD
- KITT -0.28
- LVTX -0.01
- Stochastic Oscillator
- KITT 2.83
- LVTX 41.67
About KITT Nauticus Robotics Inc.
Nauticus Robotics Inc develops fully electric autonomous robotic solutions for subsea applications. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing related software to both the commercial and defense business sectors. The company's addressable markets include upstream, midstream, and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research, and subsea mining.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.